Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anke Hoskins"'
Autor:
Deirdre A. Collins, Anke Hoskins, Thomas Snelling, Kalpani Senasinghe, Jacinta Bowman, Natalie A. Stemberger, Amanda J. Leach, Deborah Lehmann
Publikováno v:
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Abstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced to prevent invasive pneumococcal disease (IPD) in Western Australian (WA) Aboriginal people in 2001. PCV13 replaced PCV7 in July 2011, covering six additional pneum
Externí odkaz:
https://doaj.org/article/69213d6870e949e3909c5d8c3f8582b1
Autor:
Deirdre A Collins, Anke Hoskins, Jacinta Bowman, Jade Jones, Natalie A Stemberger, Peter C Richmond, Amanda J Leach, Deborah Lehmann
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
BACKGROUND: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. The seven-valent pneumococcal conjugate vaccine (7vPCV) was given in a 2-4-6-month schedule from 2001, with a 23-valent pneumococcal
Externí odkaz:
https://doaj.org/article/3bb905a781294a2d96d08445c629ed61
Autor:
Christobel Saunders, Tara Nababan, Anke Hoskins, Jeanie Leong, Neli S. Slavova-Azmanova, Emily Watters
Publikováno v:
Australian journal of primary health. 26(2)
Lung cancer care spans both hospital- and community-based healthcare settings, and suboptimal communication between healthcare providers impacts on continuity and quality of care. Patients’ experiences regarding: (1) communication between healthcar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1b59d7dcd89d8790042b3c1dd3d1ee
https://pubmed.ncbi.nlm.nih.gov/32290950
https://pubmed.ncbi.nlm.nih.gov/32290950
Autor:
Anke Hoskins, Amanda J. Leach, Jacinta Bowman, Tom Snelling, Deborah Lehmann, Deirdre A. Collins, Natalie A. Stemberger, Kalpani Senasinghe
Publikováno v:
Pneumonia
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced to prevent invasive pneumococcal disease (IPD) in Western Australian (WA) Aboriginal people in 2001. PCV13 replaced PCV7 in July 2011, covering six additional pneumococcal s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b556bd6f2ec7d901d2da67464475b548
https://doi.org/10.1186/s41479-017-0038-x
https://doi.org/10.1186/s41479-017-0038-x
Autor:
Peter Richmond, Natalie A. Stemberger, Deirdre A. Collins, Amanda J. Leach, Deborah Lehmann, Anke Hoskins, Jacinta Bowman, Jade Jones
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
BACKGROUND: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. The seven-valent pneumococcal conjugate vaccine (7vPCV) was given in a 2-4-6-month schedule from 2001, with a 23-valent pneumococcal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe33f6cb76858dd17b243d200348023
https://doi.org/10.1371/journal.pone.0082280
https://doi.org/10.1371/journal.pone.0082280